In vitro regulation of corticotropin-releasing hormone.
Studies involving regulation of corticotropin-releasing hormone (CRH) in vitro have been used to validate findings obtained in vivo and more importantly have been used as model systems to better understand signalling mechanisms responsible for the expression of the CRH gene and peptide. Many in vitro studies examining CRH have utilized hypothalamic tissue while a few have focused on the amygdala. Clonal cell lines have also been utilized as models of central nervous system CRH neurons. Stimuli that have been implicated in regulating hypothalamic CRH regulation in vitro include protein kinase A (PKA) and protein kinase C (PKC) activators, glucocorticoids, biogenic amines, cytokines and the gaseous neurotransmitters. Amygdalar CRH levels in vitro are affected by some of the same stimuli that regulate hypothalamic CRH; however there is evidence supporting differential regulation of CRH in these two brain regions by some of the same stimuli. Only a few studies in aggregate have investigated signal transduction mechanisms and these studies have focused on PKA- and glucocorticoid-mediated changes in CRH expression. Thus, much more investigative work in better understanding CRH regulation in vitro is needed.
Kasckow
J W
JW
Psychiatry Service (116A), Cincinnati VAMC, 3200 Vine Street, OH 45220, USA. jkasckow@pol.net
Aguilera
G
G
Mulchahey
J J
JJ
Sheriff
S
S
Herman
J P
JP
D000679:Amygdala / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D002478:Cells, Cultured; D003346:Corticotropin-Releasing Hormone / Q000096:biosynthesis / Q000235:genetics*; D005786:Gene Expression Regulation; D007031:Hypothalamus / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*
D003346:Corticotropin-Releasing Hormone